SCHOTT Pharma new Serbia plant strengthens competitiveness in Europe

After breaking ground in December 2023, SCHOTT Pharma has inaugurated a new manufacturing facility in Jagodina, central Serbia, on April 10.

“At a time when global tariffs and duties are rising and other European-based glass ampoule manufacturers are closing their doors, we can offer our regional customers a clear long-term perspective on how to secure their local supply chain,” said Andreas Reisse, CEO of SCHOTT Pharma. The new site in Jagodina will manufacture glass ampoules for the storage of injectable medications such as analgesics, anti-inflammatories and anesthetics.

With over 40 percent of the world’s commercial injectable drugs stored in glass ampoules, SCHOTT Pharma’s new ampoule production in Serbia will continue to help the pharmaceutical industry safely deliver medicines to patients. The new facility is equipped with modern manufacturing technology and inspection systems to produce products to the highest quality standards.

“With skilled workers from one of the most important industrial regions in Serbia joining our global production network, a close exchange of expertise and experience with the teams in Europe, and upgraded equipment, we look forward to reliably supplying our customers with the highest quality from here,” said Denis Nikitin, site manager of Jagodina.

SCHOTT Pharma’s extensive Type I borosilicate glass ampoule portfolio ranges from clear or amber glass types to different shapes (B, C, D) and breakage systems (one point cut, scoring, color break) and is available with or without printing. It includes more than a thousand different articles, all manufactured in accordance with current Good Manufacturing Practices (cGMP).

With the new site in Serbia, SCHOTT Pharma is adding a further location to its global manufacturing network, which now includes a total of 15 countries. It builds on the company’s existing foundation and pharmaceutical manufacturing presence in Europe, which already plays an important role in supplying the global industry with drug containment solutions.